Search

Your search keyword '"Mandrup-Poulsen T"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Mandrup-Poulsen T" Remove constraint Author: "Mandrup-Poulsen T" Journal diabetologia Remove constraint Journal: diabetologia
50 results on '"Mandrup-Poulsen T"'

Search Results

1. Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children

7. Proliferation of sorted human and rat beta cells

16. Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1?-mediated toxicity through inhibition of multiple nuclear factor-?B-regulated proapoptotic pathways

23. Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes.

27. The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation.

28. IL-1β-induced chemokine and Fas expression are inhibited by suppressor of cytokine signalling-3 in insulin-producing cells.

29. Proliferation of sorted human and rat beta cells.

30. Plasma cytokine levels in young and elderly twins: genes versus environment and relation to in vivo insulin action.

31. Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays

33. IL-1β induced protein changes in diabetes prone BB rat islets of Langerhans identified by proteome analysis T. Sparre et al.: Proteome analysis of BB rat islets.

34. Repetitive in vivo treatment with human recombinant interleukin-1 β modifies Beta-cell function in normal rats.

35. Insulin autoantibodies are associated with islet cell antibodies; their relation to insulin antibodies and B-cell function in diabetic children.

36. Interleukin 1 dose-dependently affects the biosynthesis of (pro)insulin in isolated rat islets of Langerhans.

37. Affinity-purified human Interleukin I is cytotoxic to isolated islets of Langerhans.

38. Increased reduction in fasting C-peptide is associated with islet cell antibodies in Type 1 (insulin-dependent) diabetic patients.

39. Insulin-gene flanking sequences, diabetes mellitus and atherosclerosis: a review.

40. 35th Annual Meeting of the European Association for the Study of Diabetes

41. Repetitive in vivo treatment with human recombinant interleukin-1βmodifies Beta-cell function in normal rats

42. Erratum: Diabetologia (2001) 44: 2115–2133.

43. No direct effect of SGLT2 activity on glucagon secretion.

44. Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.

45. Inhibition of beta cell growth and function by bone morphogenetic proteins.

46. Extracellular signal-regulated kinase is essential for interleukin-1-induced and nuclear factor kappaB-mediated gene expression in insulin-producing INS-1E cells.

47. Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated proapoptotic pathways.

48. On the pathogenesis of IDDM.

49. Repetitive in vivo treatment with human recombinant interleukin-1 beta modifies beta-cell function in normal rats.

50. Functional and morphological effects of interleukin-1 beta on the perfused rat pancreas.

Catalog

Books, media, physical & digital resources